Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Uveitis Treatment Market, by Drug Class
1.4.2 Europe Uveitis Treatment Market, by Disease Type
1.4.3 Europe Uveitis Treatment Market, by Distribution Channel
1.4.4 Europe Uveitis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Uveitis Treatment Market by Drug Class
3.1 Europe Anti-inflammatory Market by Country
3.2 Europe Immunotherapy & Targeted Therapies Market by Country
3.3 Europe Antimicrobial Drugs Market by Country
3.4 Europe Other Drug Class Market by Country
Chapter 4. Europe Uveitis Treatment Market by Disease Type
4.1 Europe Anterior Uveitis Market by Country
4.2 Europe Posterior Uveitis Market by Country
4.3 Europe Intermediate Uveitis Market by Country
4.4 Europe Other Diseases Market by Country
Chapter 5. Europe Uveitis Treatment Market by Distribution Channel
5.1 Europe Hospital Pharmacies Market by Country
5.2 Europe Retail Pharmacies Market by Country
5.3 Europe Online stores Market by Country
Chapter 6. Europe Uveitis Treatment Market by Country
6.1 Germany Uveitis Treatment Market
6.1.1 Germany Uveitis Treatment Market by Drug Class
6.1.2 Germany Uveitis Treatment Market by Disease Type
6.1.3 Germany Uveitis Treatment Market by Distribution Channel
6.2 UK Uveitis Treatment Market
6.2.1 UK Uveitis Treatment Market by Drug Class
6.2.2 UK Uveitis Treatment Market by Disease Type
6.2.3 UK Uveitis Treatment Market by Distribution Channel
6.3 France Uveitis Treatment Market
6.3.1 France Uveitis Treatment Market by Drug Class
6.3.2 France Uveitis Treatment Market by Disease Type
6.3.3 France Uveitis Treatment Market by Distribution Channel
6.4 Russia Uveitis Treatment Market
6.4.1 Russia Uveitis Treatment Market by Drug Class
6.4.2 Russia Uveitis Treatment Market by Disease Type
6.4.3 Russia Uveitis Treatment Market by Distribution Channel
6.5 Spain Uveitis Treatment Market
6.5.1 Spain Uveitis Treatment Market by Drug Class
6.5.2 Spain Uveitis Treatment Market by Disease Type
6.5.3 Spain Uveitis Treatment Market by Distribution Channel
6.6 Italy Uveitis Treatment Market
6.6.1 Italy Uveitis Treatment Market by Drug Class
6.6.2 Italy Uveitis Treatment Market by Disease Type
6.6.3 Italy Uveitis Treatment Market by Distribution Channel
6.7 Rest of Europe Uveitis Treatment Market
6.7.1 Rest of Europe Uveitis Treatment Market by Drug Class
6.7.2 Rest of Europe Uveitis Treatment Market by Disease Type
6.7.3 Rest of Europe Uveitis Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 AbbVie, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals:
7.2 Alimera Sciences, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Product Launches and Product Expansions:
7.3 Enzo Biochem, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Amgen, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Research & Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Product Launches and Product Expansions:
7.4.4.2 Partnerships, Collaborations, and Agreements:
7.5 Bausch Health Companies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Clearside Biomedical, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Research & Development Expense
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 EyePoint Pharmaceuticals, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Santen Pharmaceutical Co., Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Topivert Ltd.
7.9.1 Company Overview
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Recent strategies and developments:
7.10.4.1 Acquisition and Mergers:
7.10.4.2 Approvals:
7.10.5 Research & Development Expense



List of Tables


TABLE 1 EUROPE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 4 EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 5 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE OTHER DRUG CLASS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE OTHER DRUG CLASS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 14 EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 15 EUROPE ANTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE ANTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE POSTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE POSTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 EUROPE INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE OTHER DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE OTHER DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE ONLINE STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE ONLINE STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE UVEITIS TREATMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE UVEITIS TREATMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 GERMANY UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 34 GERMANY UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 35 GERMANY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 36 GERMANY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 37 GERMANY UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 38 GERMANY UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 39 GERMANY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 40 GERMANY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 41 UK UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 42 UK UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 43 UK UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 44 UK UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 45 UK UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 46 UK UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 47 UK UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 48 UK UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 49 FRANCE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 50 FRANCE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 51 FRANCE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 52 FRANCE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 53 FRANCE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 54 FRANCE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 55 FRANCE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 56 FRANCE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 57 RUSSIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 58 RUSSIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 59 RUSSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 60 RUSSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 61 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 62 RUSSIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 65 SPAIN UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 66 SPAIN UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 67 SPAIN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 68 SPAIN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 69 SPAIN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 70 SPAIN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 71 SPAIN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 72 SPAIN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 73 ITALY UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 74 ITALY UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 75 ITALY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 76 ITALY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 77 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 78 ITALY UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 79 ITALY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 80 ITALY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 81 REST OF EUROPE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 82 REST OF EUROPE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 83 REST OF EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 84 REST OF EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 85 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 86 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 87 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 88 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 89 KEY INFORMATION – ABBVIE, INC.
TABLE 90 KEY INFORMATION – ALIMERA SCIENCES, INC.
TABLE 91 KEY INFORMATION – ENZO BIOCHEM, INC.
TABLE 92 KEY INFORMATION – AMGEN, INC.
TABLE 93 KEY INFORMATION – BAUSCH HEALTH COMPANIES, INC.
TABLE 94 KEY INFORMATION – CLEARSIDE BIOMEDICAL, INC.
TABLE 95 KEY INFORMATION – EYEPOINT PHARMACEUTICALS, INC.
TABLE 96 KEY INFORMATION – SANTEN PHARMACEUTICAL CO., LTD.
TABLE 97 KEY INFORMATION – TOPIVERT LTD.
TABLE 98 KEY INFORMATION – NOVARTIS AG

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH